NEW YORK, Dec. 21, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Kindred Healthcare Inc. ("KND" or the "Company") (NYSE: KND) in connection with the proposed acquisition of the Company by Humana Inc. ("HUM") (NYSE: HUM) and two private equity firms. Under the terms of the acquisition agreement, shareholders of KND will be entitled to receive $9.00 in cash for each KND share they own.
WeissLaw is investigating whether KND's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $11.00, or $2.00 above the offer price. Additionally, KND shares traded for $11.90, or nearly $3.00 above the offer price, as recently as July 3.
Given these facts, WeissLaw is investigating whether KND shareholders will obtain their fair and proportionate share of the Company's continued success and future growth prospects. If you own KND shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at email@example.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at firstname.lastname@example.org or fill out the form on our website, http://www.weisslawllp.com/kindred-healthcare-inc/
SOURCE WeissLaw LLP